Study Results of Real-World Experience of Lojuxta

Released : 27 Apr 2017 07:00

RNS Number : 4665D
Amryt Pharma PLC
27 April 2017


Unlike statins, ezetimibe and PCSK-9 inhibitors, Lojuxta works independently of LDL receptors which have little to no functionality in HoFH. Through this different mechanism of action,


This information is provided by RNS
The company news service from the London Stock Exchange